Literature DB >> 31128889

Germline Variants Impact Somatic Events during Tumorigenesis.

Johnny R Ramroop1, Madelyn M Gerber2, Amanda Ewart Toland3.   

Abstract

Cancer is characterized by diverse genetic alterations in both germline and somatic genomes that disrupt normal biology and provide a selective advantage to cells during tumorigenesis. Germline and somatic genomes have been extensively studied independently, leading to numerous biological insights. Analyses integrating data from both genomes have identified genetic variants impacting somatic events in tumors, including hotspot driver mutations. Interactions among specific germline variants and somatic events influence cancer subtypes, treatment response, and clinical outcomes. Investigation of these complex interactions is increasing our understanding of aberrant pathways in tumors that may uncover novel therapeutic targets. Here, we review the literature describing the role of germline genetic variants in promoting the selection and generation of specific mutations during tumorigenesis.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  GWAS; allele-specific imbalance; germline variant; pathogenic variant; somatic mutation

Mesh:

Year:  2019        PMID: 31128889      PMCID: PMC6571050          DOI: 10.1016/j.tig.2019.04.005

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  57 in total

1.  Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.

Authors:  R Gryfe; H Kim; E T Hsieh; M D Aronson; E J Holowaty; S B Bull; M Redston; S Gallinger
Journal:  N Engl J Med       Date:  2000-01-13       Impact factor: 91.245

2.  A subset of skin tumor modifier loci determines survival time of tumor-bearing mice.

Authors:  H Nagase; J H Mao; A Balmain
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine.

Authors:  Maria Planck; Kajsa Ericson; Zofia Piotrowska; Britta Halvarsson; Eva Rambech; Mef Nilbert
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

4.  High frequency of microsatellite instability and loss of mismatch-repair protein expression in patients with double primary tumors of the endometrium and colorectum.

Authors:  Maria Planck; Eva Rambech; Gabriela Möslein; Wolfram Müller; Håkan Olsson; Mef Nilbert
Journal:  Cancer       Date:  2002-05-01       Impact factor: 6.860

5.  Linkage disequilibrium and physical mapping of Pas1 in mice.

Authors:  G Manenti; A Stafford; L De Gregorio; M Gariboldi; F S Falvella; P Avner; T A Dragani
Journal:  Genome Res       Date:  1999-07       Impact factor: 9.043

6.  Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis.

Authors:  Thomas C Putti; Dalia M Abd El-Rehim; Emad A Rakha; Claire E Paish; Andrew H S Lee; Sarah E Pinder; Ian O Ellis
Journal:  Mod Pathol       Date:  2005-01       Impact factor: 7.842

7.  Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human.

Authors:  Amanda Ewart-Toland; Paraskevi Briassouli; John P de Koning; Jian-Hua Mao; Jinwei Yuan; Florence Chan; Lucy MacCarthy-Morrogh; Bruce A J Ponder; Hiroki Nagase; John Burn; Sarah Ball; Maria Almeida; Spiros Linardopoulos; Allan Balmain
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

8.  Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice.

Authors:  Hiroki Nagase; Jian-Hua Mao; Allan Balmain
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

9.  Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families.

Authors:  Siobhan S Wahlberg; James Schmeits; George Thomas; Massimo Loda; Judy Garber; Sapna Syngal; Richard D Kolodner; Edward Fox
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

10.  Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types.

Authors:  Amanda Ewart-Toland; Qi Dai; Yu-Tang Gao; Hiroki Nagase; Malcolm G Dunlop; Susan M Farrington; Rebecca A Barnetson; Hoda Anton-Culver; David Peel; Argyrios Ziogas; Dongxin Lin; Xiaoping Miao; Tong Sun; Elaine A Ostrander; Janet L Stanford; Mariela Langlois; June M Chan; Jinwei Yuan; Curtis C Harris; Elise D Bowman; Gary L Clayman; Scott M Lippman; J Jack Lee; Wei Zheng; Allan Balmain
Journal:  Carcinogenesis       Date:  2005-03-31       Impact factor: 4.944

View more
  16 in total

1.  The impact of rare germline variants on human somatic mutation processes.

Authors:  Mischan Vali-Pour; Ben Lehner; Fran Supek
Journal:  Nat Commun       Date:  2022-06-28       Impact factor: 17.694

2.  Common germline-somatic variant interactions in advanced urothelial cancer.

Authors:  Aram Vosoughi; Tuo Zhang; Kyrillus S Shohdy; Panagiotis J Vlachostergios; David C Wilkes; Bhavneet Bhinder; Scott T Tagawa; David M Nanus; Ana M Molina; Himisha Beltran; Cora N Sternberg; Samaneh Motanagh; Brian D Robinson; Jenny Xiang; Xiao Fan; Wendy K Chung; Mark A Rubin; Olivier Elemento; Andrea Sboner; Juan Miguel Mosquera; Bishoy M Faltas
Journal:  Nat Commun       Date:  2020-12-03       Impact factor: 14.919

Review 3.  Structural variant detection in cancer genomes: computational challenges and perspectives for precision oncology.

Authors:  Ianthe A E M van Belzen; Alexander Schönhuth; Patrick Kemmeren; Jayne Y Hehir-Kwa
Journal:  NPJ Precis Oncol       Date:  2021-03-02

4.  Somatic mutational profiles and germline polygenic risk scores in human cancer.

Authors:  Yuxi Liu; Alexander Gusev; Yujing J Heng; Ludmil B Alexandrov; Peter Kraft
Journal:  Genome Med       Date:  2022-02-11       Impact factor: 15.266

5.  Prevalence and Spectrum of Predisposition Genes With Germline Mutations Among Chinese Patients With Bowel Cancer.

Authors:  Zhengyong Xie; Yongli Ke; Junyong Chen; Zehang Li; Changzheng Wang; Yuhong Chen; Hongliang Ding; Liyang Cheng
Journal:  Front Genet       Date:  2022-01-27       Impact factor: 4.599

Review 6.  Germline Variants That Affect Tumor Progression.

Authors:  Ajay Chatrath; Aakrosh Ratan; Anindya Dutta
Journal:  Trends Genet       Date:  2020-11-14       Impact factor: 11.639

7.  Rare Germline Variants in Chordoma-Related Genes and Chordoma Susceptibility.

Authors:  Sally Yepes; Nirav N Shah; Jiwei Bai; Hela Koka; Chuzhong Li; Songbai Gui; Mary Lou McMaster; Yanzi Xiao; Kristine Jones; Mingyi Wang; Aurelie Vogt; Bin Zhu; Bin Zhu; Amy Hutchinson; Meredith Yeager; Belynda Hicks; Brian Carter; Neal D Freedman; Laura Beane-Freeman; Stephen J Chanock; Yazhuo Zhang; Dilys M Parry; Xiaohong R Yang; Alisa M Goldstein
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

8.  Ancestry-specific predisposing germline variants in cancer.

Authors:  Ninad Oak; Andrew D Cherniack; R Jay Mashl; Fred R Hirsch; Li Ding; Rameen Beroukhim; Zeynep H Gümüş; Sharon E Plon; Kuan-Lin Huang
Journal:  Genome Med       Date:  2020-05-29       Impact factor: 15.266

Review 9.  Genetic Predisposition to Solid Pediatric Cancers.

Authors:  Mario Capasso; Annalaura Montella; Matilde Tirelli; Teresa Maiorino; Sueva Cantalupo; Achille Iolascon
Journal:  Front Oncol       Date:  2020-10-28       Impact factor: 6.244

Review 10.  Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era.

Authors:  Eduard Porta-Pardo; Alfonso Valencia; Adam Godzik
Journal:  FEBS Lett       Date:  2020-04-28       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.